Langerhans cell histiocytosis with central nervous system involvement: Follow-up by FDG-PET during treatment with cladribine

Pediatric Blood and Cancer

Volumn 44, Issue 3, 2005, Pages 286-288

  Büchler, Tomas ^a   Cervinek, Libor ^a   Belohlavek, Otakar ^b   Kantorova, Iva ^b   Mechl, Marek ^a   Nebesky, Tomas ^a   Vorlicek, Jiri ^a   Adam, Zdenek ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b NA HOMOLCE HOSPITAL   (Czech Republic)

Author keywords

Chemotherapy; Langerhans cell histiocytosis; Positron emission tomography

Indexed keywords

CLADRIBINE; CORTICOSTEROID; CYTOSTATIC AGENT; FLUORODEOXYGLUCOSE F 18; PHOSPHONIC ACID DERIVATIVE;

ADULT; ANAMNESIS; ARTICLE; ATAXIA; BRAIN STEM INJURY; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBELLUM INJURY; DIPLOPIA; DISEASE COURSE; DRUG SAFETY; DRUG USE; EXPERIENCE; FOLLOW UP; HISTIOCYTOSIS X; HUMAN; LEUKOPENIA; MALE; MENTAL DETERIORATION; NEUROPSYCHIATRY; OSTEOPOROSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELAPSE; REMISSION;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; CLADRIBINE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY;

EID: 13444311532     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20175     Document Type: Article

References (9)

1. Grois NG, Favara BE, Mostbeck GH, et al. Central nervous system disease in Langerhans cell histiocytosis. Hematol Oncol Clin North Am 1998;12:287-305.
2. Burn DJ, Watson JD, Roddie M, et al. Langerhans' cell histiocytosis and the nervous system. J Neurol 1992;239:345-350.
3. Barthez MA, Araujo E, Donadieu J. Langerhans cell histiocytosis and the central nervous system in childhood: Evolution and prognostic factors. Results of a collaborative study. J Child Neurol 2000;15:150-156.
4. Stine KC, Saylors RL, Williams LL, et al. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol 1997;29:288-292.
5. Saven A, Burian C. Cladribine activity in adult langerhans-cell histiocytosis. Blood 1999;93:4125-4130.
6. Liliemark J. The clinical pharmacokinetics of cladribine. Clin Pharmacokinet 1997;32:120-131.
7. Calming U, Bernstrand C, Mosskin M, et al. Brain 18-FDG PET scan in central nervous system langerhans cell histiocytosis. J Pediatr 2002;141:435-440.
8. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X) - A clonal proliferative disease. N Engl J Med 1994;331:154-160.
9. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995;127:1-11.